EyePoint Pharmaceuticals Stock Income Statements

EyePoint Pharmaceuticals Quarterly Income Statements Chart

Quarterly

Annual

Operating Profit

Net Income

EyePoint Pharmaceuticals Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-09-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2005-06-30

revenues:
product sales		715,000	774,000	664,000	1,068,000	658,000	749,000	816,000	5,273,000	7,394,000	9,857,000	9,720,000	11,318,000	9,010,000	11,185,000	8,587,000	8,738,000	6,802,000	6,680,000	5,758,000	3,706,000	4,687,000	7,883,000	1,009,000	6,705,000	1,227,000
license and collaboration agreements	5,333,000	11,049,000	10,590,000	9,561,000	7,782,000	10,563,000	13,029,000	14,137,000	3,597,000	34,000	202,000	52,000	49,000	59,000
royalty income		12,689,000	224,000	299,000	627,000	463,000	250,000	249,000	235,000	255,000	474,000	240,000	198,000	225,000	197,000	313,000	181,000	180,000	99,000	402,000	381,000	782,000	514,000	446,000	500,000	720,000	430,000	404,000	472,000	245,000	240,000	218,000	269,000	243,000	278,000	274,000	384,000	286,000	353,000	218,000	357,000	226,000	286,000	316,000	292,000	424,000	315,000	274,000	390,000	384,000	442,000	380,000	426,000	198,000	321,000	304,000	326,000	402,000	394,000	25,000	27,000	37,000	37,000	27,000	55,000	41,000	56,000	39,000	39,000	14,000
total revenues	5,333,000	24,453,000	11,588,000	10,524,000	9,477,000	11,684,000	14,028,000	15,202,000	9,105,000	7,683,000	10,533,000	10,012,000	11,565,000	9,294,000	11,544,000	9,059,000	9,013,000	7,323,000	7,131,000	15,695,000	4,122,000	7,489,000	8,633,000	2,509,000	7,210,000	2,012,000	486,000	928,000	933,000	385,000	701,000	590,000	5,971,000	277,000	304,000	324,000	526,000	466,000	409,000	328,000	521,000	25,307,000	292,000	1,992,000	592,000	597,000	492,000	513,000	585,000	553,000	699,000	538,000	630,000	1,659,000	3,715,000	360,000	414,000	476,000	15,722,000	515,000	3,433,000	3,383,000	3,223,000	3,163,000	2,970,000	2,806,000	2,703,000	542,000	128,000	103,000
operating expenses:
cost of sales	165,000	805,000	816,000	736,000	1,401,000	759,000
gross profit
yoy
qoq
gross margin %
research and development	55,498,000	58,574,000	43,372,000	29,542,000	29,822,000	30,139,000	17,951,000	17,363,000	15,730,000	13,618,000	15,543,000	11,162,000	12,992,000	9,945,000	8,918,000	8,498,000	5,605,000	5,479,000	5,205,000	4,090,000	3,276,000	4,853,000	4,131,000	3,484,000	3,955,000	3,797,000	6,233,000	3,325,000	4,269,000	3,819,000	4,213,000	3,324,000	3,165,000	4,178,000	4,104,000	3,074,000	3,721,000	3,482,000	3,198,000	3,339,000	2,767,000	2,784,000	2,306,000	2,269,000	2,494,000	2,504,000	2,320,000	1,587,000	1,575,000	1,523,000	1,410,000	1,508,000	1,992,000	2,129,000	1,851,000	1,737,000	1,534,000	1,742,000	1,786,000	1,680,000	1,728,000	1,800,000	1,830,000	1,892,000	2,057,000	2,228,000	2,404,000	3,605,000	4,946,000
sales and marketing	35,000	35,000	51,000	24,000	50,000	6,000	185,000	479,000	5,288,000	5,737,000	5,915,000	6,016,000	6,883,000	6,693,000	7,811,000	7,374,000	6,659,000	5,659,000	5,810,000	5,269,000	6,089,000	8,125,000	7,399,000	7,778,000	7,284,000	7,311,000	3,646,000
general and administrative	11,862,000	13,876,000	12,588,000	12,970,000	12,750,000	14,101,000	11,248,000	10,556,000	9,056,000	9,242,000	8,496,000	9,212,000	8,557,000	8,548,000	9,217,000	6,060,000	5,184,000	5,115,000	5,777,000	5,796,000	4,792,000	4,360,000	4,149,000	4,365,000	4,815,000	4,610,000	4,161,000	2,281,000	2,472,000	2,572,000	2,624,000	2,426,000	2,900,000	3,285,000	2,656,000	2,346,000	2,043,000	1,968,000	2,411,000	2,041,000	1,870,000	1,734,000	2,000,000	1,946,000	1,711,000	1,811,000	2,153,000	1,738,000	1,658,000	1,620,000	1,599,000	1,757,000	1,451,000	2,061,000	2,172,000	1,762,000	2,001,000	2,169,000	1,762,000	1,698,000	1,818,000	1,690,000	1,448,000	2,052,000	2,334,000	2,957,000
total operating expenses	67,560,000	73,290,000	56,827,000	43,272,000	44,023,000	45,005,000	30,382,000	29,600,000	31,866,000	29,237,000	54,268,000	28,410,000	30,781,000	27,578,000	29,594,000	24,372,000	19,992,000	18,258,000	19,868,000	17,652,000	15,274,000	18,933,000	17,618,000	16,569,000	17,375,000	16,663,000	14,040,000	5,606,000	6,741,000	6,391,000	6,837,000	5,750,000	6,065,000	7,463,000	6,760,000	5,420,000	5,764,000	5,450,000	5,609,000	5,380,000	4,637,000	4,518,000	4,304,000	4,211,000	4,133,000	4,315,000	4,473,000	3,325,000	3,233,000	3,143,000	3,009,000	3,265,000	18,273,000	4,190,000	4,023,000	3,499,000	3,535,000	3,911,000	3,548,000	3,378,000	3,546,000	3,490,000	3,278,000	3,944,000	4,391,000	5,185,000	67,852,000	7,151,000	8,164,000	5,316,000
income from operations	-62,227,000	-48,837,000	-45,239,000	-32,748,000	-34,546,000	-33,321,000	-16,354,000	-14,398,000	-22,761,000	-21,554,000	-43,735,000	-18,398,000	-19,216,000	-18,284,000	-18,050,000	-15,313,000	-10,979,000	-10,935,000	-12,737,000	-1,957,000	-11,152,000	-11,444,000	-8,985,000	-14,060,000	-10,165,000	-14,651,000		-4,678,000	-5,808,000	-6,006,000	-3,110,000	-5,160,000	-94,000	-7,186,000	-3,829,500	-5,096,000	-5,238,000	-4,984,000	2,905,250	-5,052,000	-4,116,000	20,789,000	-2,369,500	-2,219,000	-3,541,000	-3,718,000	-2,012,500	-2,812,000	-2,648,000	-2,590,000	-5,725,250	-2,727,000	-17,643,000	-2,531,000	-2,423,750	-3,139,000	-3,121,000	-3,435,000	-770,750	-2,863,000	-113,000	-107,000	-1,145,250	-781,000	-1,421,000	-2,379,000	-4,964,500	-6,609,000	-8,036,000	-5,213,000
yoy	80.13%	46.57%	176.62%	127.45%	51.78%	54.59%	-62.61%	-21.74%	18.45%	17.88%	142.30%	20.15%	75.03%	67.21%	41.71%	682.47%	-1.55%	-4.45%	41.76%	-86.08%	9.71%	-21.89%		200.56%	75.02%	143.94%		-9.34%	6078.72%	-16.42%	-18.79%	1.26%	-98.21%	44.18%	-231.81%	0.87%	27.26%	-123.97%	-222.61%	127.67%	16.24%	-659.14%	17.74%	-21.09%	33.72%	43.55%	-64.85%	3.12%	-84.99%	2.33%	136.21%	-13.13%	465.30%	-26.32%	214.47%	9.64%	2661.95%	3110.28%	-32.70%	266.58%	-92.05%	-95.50%	-76.93%	-88.18%	-82.32%	-54.36%
qoq	27.42%	7.95%	38.14%	-5.20%	3.68%	103.75%	13.59%	-36.74%	5.60%	-50.72%	137.72%	-4.26%	5.10%	1.30%	17.87%	39.48%	0.40%	-14.15%	550.84%	-82.45%	-2.55%	27.37%	-36.10%	38.32%	-30.62%			-19.46%	-3.30%	93.12%	-39.73%	5389.36%	-98.69%	87.65%	-24.85%	-2.71%	5.10%	-271.55%	-157.51%	22.74%	-119.80%	-977.36%	6.78%	-37.33%	-4.76%	84.75%	-28.43%	6.19%	2.24%	-54.76%	109.95%	-84.54%	597.08%	4.42%	-22.79%	0.58%	-9.14%	345.67%	-73.08%	2433.63%	5.61%	-90.66%	46.64%	-45.04%	-40.27%	-52.08%	-24.88%	-17.76%	54.15%
operating margin %
other income:
interest and other income	2,894,000	3,642,000	3,944,000	3,387,000	3,720,000	4,037,000	2,338,000	1,786,000	1,623,000	1,202,000	1,064,000	640,000	362,000	61,000	6,000	6,000	280,000	1,000		-4,000	8,000	54,000	362,000	183,000	266,000	243,000	129,000	25,000	26,000	23,000	20,000	20,000	27,000	24,000	31,000	21,000	10,000	10,000
total other income	2,894,000	3,642,000	3,930,000	3,387,000	3,720,000	4,037,000	2,338,000	1,786,000	-159,000	390,000	283,000	-22,000	-190,000	-2,692,000	-1,382,000	-1,382,000	969,000	-1,345,000	-2,732,000	-1,844,000	-1,798,000	-1,730,000	-1,425,000	-1,587,000	-1,333,000	-4,587,000													6,000	10,000			2,000	1,000	1,000	1,000	2,000	3,000	3,000	6,000	8,000	11,000	139,000	49,000	19,000	341,000	461,000	336,000	884,000	230,000	79,000	-1,508,000	-566,000	40,000	277,000	1,423,000	1,326,000	1,093,000	2,225,000	4,210,000
net income before income taxes	-59,333,000
benefit from income taxes	-93,000
net income	-59,426,000	-45,195,000	-41,399,000	-29,361,000	-30,826,000	-29,284,000	-14,099,000	-12,612,000	-22,920,000	-21,164,000	-43,452,000	-18,420,000	-19,406,000	-20,976,000	-19,432,000	-16,695,000	-10,010,000	-12,280,000	-15,469,000	-3,801,000	-12,950,000	-13,174,000	-10,410,000	-15,647,000	-11,498,000	-19,238,000	-33,126,000	-6,978,000	-5,782,000	-5,983,000	-6,116,000	-5,140,000	-67,000	-7,162,000	-6,387,000	-5,041,000	-5,186,000	-4,933,000	-5,146,000	-4,998,000	-4,075,000	20,566,000	-3,967,000	-2,187,000	-3,514,000	-3,687,000	-3,947,000	-2,794,000	-2,608,000	-2,551,000	-2,262,000	-2,686,000	-17,460,000	-2,427,000	-140,000	-2,685,000	-2,695,000	-3,108,000	13,073,000	-2,705,000	-24,000	-1,591,000	-534,000	-636,000	-870,000	-471,000	-63,579,000	-5,501,000	-5,795,000	-795,000
yoy	92.78%	54.33%	193.63%	132.80%	34.49%	38.37%	-67.55%	-31.53%	18.11%	0.90%	123.61%	10.33%	93.87%	70.81%	25.62%	339.23%	-22.70%	-6.79%	48.60%	-75.71%	12.63%	-31.52%	-68.57%	124.23%	98.86%	221.54%	441.63%	35.76%	8529.85%	-16.46%	-4.24%	1.96%	-98.71%	45.19%	24.12%	0.86%	27.26%	-123.99%	29.72%	128.53%	15.96%	-657.80%	0.51%	-21.73%	34.74%	44.53%	74.49%	4.02%	-85.06%	5.11%	1515.71%	0.04%	547.87%	-21.91%	-101.07%	-0.74%	11129.17%	95.35%	-2548.13%	325.31%	-97.24%	237.79%	-99.16%	-88.44%	-84.99%	-40.75%
qoq	31.49%	9.17%	41.00%	-4.75%	5.27%	107.70%	11.79%	-44.97%	8.30%	-51.29%	135.90%	-5.08%	-7.48%	7.95%	16.39%	66.78%	-18.49%	-20.62%	306.97%	-70.65%	-1.70%	26.55%	-33.47%	36.08%	-40.23%	-41.92%	374.72%	20.68%	-3.36%	-2.17%	18.99%	7571.64%	-99.06%	12.13%	26.70%	-2.80%	5.13%	-4.14%	2.96%	22.65%	-119.81%	-618.43%	81.39%	-37.76%	-4.69%	-6.59%	41.27%	7.13%	2.23%	12.78%	-15.79%	-84.62%	619.41%	1633.57%	-94.79%	-0.37%	-13.29%	-123.77%	-583.29%	11170.83%	-98.49%	197.94%	-16.04%	-26.90%	84.71%	-99.26%	1055.77%	-5.07%	628.93%
net income margin %
net income per share							-0.375	-0.33	-0.61	-0.56	-0.395	-0.49	-0.52	-0.56	-0.355	-0.58	-0.35	-0.5	-0.06	-0.03	-0.1	-0.11	-0.113	-0.15	-0.11	-0.2
basic and diluted	-0.85	-0.65	-0.65	-0.54	-0.58	-0.55																					-440	-150	-130	-150	-90	-150
weighted-average common shares outstanding:
basic and diluted	69,926	69,767	56,298	54,449	53,206	52,913	38,904				37,317				28,758				12,836				104,307				75,170,000	45,644,000	44,530,000	39,430,000		34,366,000	34,177,000										27,444				23,044					20,803	20,803	20,757		20,177	18,531	18,531		18,480		18,294	18,263	18,262	18,262	18,262	18,166	730,519	730,519	715,938
other comprehensive income:
unrealized gain on available-for-sale securities	-91	-105	-143	379	-44
comprehensive income	-59,517	-45,300																																	15,201,360	-5,053,000	-5,211,000	-4,959,000	-11,341,752	-5,042,000	-4,123,000	20,513,000
interest expense									-435,000	-812,000	-781,000	-662,000	-552,000	-1,194,000	-1,388,000	-1,388,000	-1,376,000	-1,346,000	-1,827,000	-1,840,000	-1,806,000	-1,784,000	-1,787,000	-1,770,000	-1,599,000	-1,020,000	-815,000
loss on extinguishment of debt									-1,347,000					-1,559,000												-3,810,000
other comprehensive gain:
comprehensive loss			-41,542	-28,982	-30,870	-29,312	-14,076	-12,613	-22,921	-21,107	-43,319	-18,369	-19,592	-21,029	-19,432	-16,695	-10,010	-12,280	-15,468	-3,801	-12,950	-13,174	-10,410	-15,647	-11,497	-19,238	-33,126,000	-6,977,000	-5,783,000	-5,979,000	-3,099,250	-5,139,000	-82,000										9,275,769	-2,183,000	-3,484,000	-3,622,000	7,969,078	-2,881,000	-2,616,000	-2,484,000
weighted-average shares outstanding:
basic and diluted	69,926	69,767	56,298	54,449	53,206	52,913	38,904				37,317				28,758				12,836				104,307				75,170,000	45,644,000	44,530,000	39,430,000		34,366,000	34,177,000										27,444				23,044					20,803	20,803	20,757		20,177	18,531	18,531		18,480		18,294	18,263	18,262	18,262	18,262	18,166	730,519	730,519	715,938
other comprehensive loss:
unrealized gain on available-for-sale securities, net of tax of 0 for periods presented						-28	23	-1	-1	57	-47	51
cost of sales, excluding amortization of acquired intangible assets							998,000	1,202,000	1,792,000	640,000	3,410,000	1,405,000	1,734,000	1,777,000	3,033,000	1,825,000	1,929,000	1,390,000	2,461,000	1,882,000	502,000	980,000	1,324,000	327,000	706,000	330,000
amortization of acquired intangible assets											205,000	615,000	615,000	615,000	615,000	615,000	615,000	615,000	615,000	615,000	615,000	615,000	615,000	615,000	615,000	615,000
net income per share							-0.375	-0.33	-0.61	-0.56	-0.395	-0.49	-0.52	-0.56	-0.355	-0.58	-0.35	-0.5	-0.06	-0.03	-0.1	-0.11	-0.113	-0.15	-0.11	-0.2
weighted-average shares outstanding – basic and diluted								38,341	37,576	37,486
gain on extinguishment of debt																	2,065,000
weighted-average shares outstanding - basic and diluted												37,338	37,322	37,253		28,766	28,744	24,735		127,945	124,771	115,530		106,938	106,238
unrealized loss on available-for-sale securities, net of tax of 0 for periods presented													-186	-53
license and collaboration agreement															148,500	159,000	94,000	341,000	2,897,500	9,535,000	35,000	2,020,000	281,250	1,054,000
foreign currency translation adjustments																									1			1,000	-1,000	4,000	29,979		-15,000		67,904	-21,000	-19,000	-28,000	140,905	-45,000	-46,000	-50,000	-99,876	5,000	30,000	65,000	30,971	-87,000	-3,000	59,000
change in fair value of derivative liability																											-18,886,000	-2,325,000
collaborative research and development																									5,000	65,000	56,000	524,000	461,000	140,000	461,000	372,000	5,702,000	34,000	26,000	50,000	142,000	180,000	56,000	110,000	164,000	25,081,000	6,000	1,676,000	300,000	173,000	177,000	239,000	195,000	169,000	257,000	158,000	204,000	1,461,000	3,394,000	56,000	88,000	74,000	15,328,000	490,000	3,406,000	3,346,000	3,186,000	3,136,000	2,915,000	2,765,000	2,647,000	503,000	89,000	89,000
weighted-average shares outstanding—basic and diluted																										95,452
operating income																											-13,554,000
net income per common share:
basic and diluted	-0.85	-0.65	-0.65	-0.54	-0.58	-0.55																					-440	-150	-130	-150	-90	-150
weighted-average common shares:
basic and diluted	69,926	69,767	56,298	54,449	53,206	52,913	38,904				37,317				28,758				12,836				104,307				75,170,000	45,644,000	44,530,000	39,430,000		34,366,000	34,177,000										27,444				23,044					20,803	20,803	20,757		20,177	18,531	18,531		18,480		18,294	18,263	18,262	18,262	18,262	18,166	730,519	730,519	715,938
other comprehensive income																												1,000	-1,000	4,000	-7,000	1,000							144,901	-44,000	-48,000	-53,000	-98,876	4,000	30,000	65,000	27,978	-87,000	-8,000	67,000
net unrealized gain on marketable securities																															-1,998	1,000			-4,997	9,000		2,000	3,996	1,000			-250	-1,000			-2,993		-5,000	8,000
income before income taxes																															-6,116,000	-5,140,000	-67,000	-7,162,000	-6,425,000	-5,075,000	-5,228,000	-4,974,000	-5,194,000	-5,042,000	-4,113,000	20,792,000	-4,010,000	-2,218,000	-3,540,000	-3,717,000	-3,979,000	-2,809,000	-2,645,000	-2,584,000	-2,302,000	-2,716,000	-17,504,000	-2,482,000	-289,000	-2,798,000	-2,660,000	-3,099,000	13,058,000	-2,633,000	-34,000	-1,615,000	-710,250	-741,000	-1,144,000	-956,000
income tax benefit																																			38,000	34,000	42,000	41,000	48,000	44,000	38,000	-226,000	43,000	31,000	26,000	30,000	32,000	15,000	37,000	33,000	40,000	30,000	44,000	55,000	149,000	113,000	-35,000	-9,000	15,000	-72,000	10,000	24,000	87,000	105,000	274,000	485,000	244,000	15,000	16,000	208,000
other comprehensive loss																																	-15,000		-15,750	-12,000	-25,000	-26,000
net income per common share:
basic																																			489.32	-150	-180	-170	-389.78	-170	-140	700
diluted																																			489.32	-150	-180	-170	-379.79	-170	-140	670
weighted-average common shares:
basic																															35,344				31,623	33,538,000	29,437,000	29,416,000	29,378	29,412,000	29,367,000	29,323,000									20,791				19,489				18,405
diluted																															35,344				31,623	33,538,000	29,437,000	29,416,000	30,584	29,412,000	29,367,000	30,765,000									20,791				19,489				18,895
net unrealized loss on marketable securities																																					-6,000				-2,000	-3,000
gain on sale of property and equipment																																											-2,000	-4,000	-72,000
interest income																																							7,000	6,000	3,000	3,000	3,000	1,000	1,000	1,000	2,000	3,000	4,000	7,000	8,000	10,000	11,000	9,000	11,000	7,000	6,000	6,000	25,000			2,000	7,000	22,000	55,000	78,000	114,000	121,000	187,000	226,000
other income																																							-1,000	4,000									-1,000	-1,000		1,000		-2,000	-2,000		-3,000	-8,000	-12,000	4,000	-4,000	9,000	46,000	-4,000	-4,000	15,000	48,000	6,000	361,000	-59,000
net income per common share - basic and diluted																																											-87.5	-80	-130	-140	-87.5	-120	-110	-110
weighted-average common shares - basic and diluted																																												27,672,000	26,953,000	25,918,000		23,297,000	23,297,000	22,294,000
impairment of intangible assets																																																					14,830,000
change in fair value of derivatives																																																					128,000	42,000	10,000	334,000	458,000	338,000	871,000	226,000	83,000	-1,519,000	-619,000	22,000	226,000	1,330,000	1,164,000	1,172,000	1,828,000	4,193,000
basic and diluted net income per share:																																																			-0.273	-0.13	-0.84		-0.113	-0.13	-0.15		-0.06	-0.15		-0.09				-0.03
basic and diluted net income per share																																																						-0.12				-0.17					-0.028	-0.03	-0.05
weighted-average common shares outstanding: basic and diluted																																																													18,317
selling, general and administrative																																																																			2,152,250	3,546,000	3,218,000	1,845,000
interest and finance costs																																																																				-206,000	-151,000	-150,000
income from continuing operations before income taxes																																																																			-63,823,000	-5,516,000	-5,811,000	-1,003,000
income from continuing operations																																																																			-63,579,000	-5,501,000	-5,795,000	-795,000
income from discontinued operations
weighted-average ordinary shares outstanding:
basic and diluted	69,926	69,767	56,298	54,449	53,206	52,913	38,904				37,317				28,758				12,836				104,307				75,170,000	45,644,000	44,530,000	39,430,000		34,366,000	34,177,000										27,444				23,044					20,803	20,803	20,757		20,177	18,531	18,531		18,480		18,294	18,263	18,262	18,262	18,262	18,166	730,519	730,519	715,938
research and development - impairment of intangible assets
in-process research and development
research and development - other																																																																						3,471,000
loss prior to elimination of loss attributable to minority interest																																																																						-795,000
loss attributable to minority interest
gain on sale of discontinued operations
net income from discontinued operations

We provide you with 20 years income statements for EyePoint Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EyePoint Pharmaceuticals stock. Explore the full financial landscape of EyePoint Pharmaceuticals stock with our expertly curated income statements.

The information provided in this report about EyePoint Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.